Literature DB >> 19763598

The NEI VFQ-25 vision-related quality of life and prevalence of eye disease in a working population.

Christoph Hirneiss1, Christine Schmid-Tannwald, Marcus Kernt, Anselm Kampik, Aljoscha S Neubauer.   

Abstract

PURPOSE: To apply the National Eye Institute 25-item Visual Function Questionnaire (VFQ-25) to a large group of working people and assess the prevalence of eye disease.
METHODS: In this cross-sectional study, 619 employees of two large enterprises in Munich, Germany, underwent complete ophthalmological examination and assessment of the vision-related quality of life by the Visual Function Questionnaire (VFQ-25, German translation). Statistical analysis including binary logistic regression to investigate predictive factors of eye disease was performed.
RESULTS: The age of the participants was mean 42 years. In 108 patients (17.4%) an ophthalmological disease was present. The mean VFQ-25 composite score was 91.1, and was not significantly different between the group with (88.8) or without (91.6) eye disease. A clear age dependency of VFQ-25 scores was seen. Most reduced subscales in eye disease were ocular pain and role difficulties. Patients with amblyopia did not show any reduction in visual quality of life (composite score 93.4). In the binary regression model, considering the clinical parameters intraocular pressure (IOP), cup/disc ratio (CDR), and spherical equivalent, as well as some of the VFQ-25 subscales, the presence of eye disease could be predicted with a high specificity of 98.7% but a low sensitivity of 12.2%.
CONCLUSIONS: Normal values of the VFQ-25 performance in a large number of working people in Germany are given with a clear age dependency. A combination of refraction, IOP, CDR and some VFQ subscales could reasonably well exclude any prevalent eye disease. For screening purposes, neither variable nor combination was sufficiently sensitive and specific.

Entities:  

Mesh:

Year:  2009        PMID: 19763598     DOI: 10.1007/s00417-009-1186-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  18 in total

1.  Psychometric performance of the NEI VFQ-25 in visually normal Latinos: the Los Angeles Latino Eye Study.

Authors:  Denise Globe; Rohit Varma; Stanley P Azen; Sylvia Paz; Elaine Yu; Susan Preston-Martin
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-04       Impact factor: 4.799

2.  Development of the 25-item National Eye Institute Visual Function Questionnaire.

Authors:  C M Mangione; P P Lee; P R Gutierrez; K Spritzer; S Berry; R D Hays
Journal:  Arch Ophthalmol       Date:  2001-07

3.  Visual quality of life after macular hole surgery: outcome and predictive factors.

Authors:  Christoph Hirneiss; Aljoscha S Neubauer; Carolin A Gass; Ingrid W Reiniger; Siegfried G Priglinger; Anselm Kampik; Christos Haritoglou
Journal:  Br J Ophthalmol       Date:  2006-10-31       Impact factor: 4.638

4.  Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons.

Authors:  C M Mangione; S Berry; K Spritzer; N K Janz; R Klein; C Owsley; P P Lee
Journal:  Arch Ophthalmol       Date:  1998-02

5.  Impact of severity and bilaterality of visual impairment on health-related quality of life.

Authors:  Rohit Varma; Joanne Wu; Kelly Chong; Stanley P Azen; Ron D Hays
Journal:  Ophthalmology       Date:  2006-08-04       Impact factor: 12.079

6.  Prevalence of dry eye disease among Japanese visual display terminal users.

Authors:  Miki Uchino; Debra A Schaumberg; Murat Dogru; Yuichi Uchino; Kazumi Fukagawa; Shigeto Shimmura; Toshihiko Satoh; Toru Takebayashi; Kazuo Tsubota
Journal:  Ophthalmology       Date:  2008-08-16       Impact factor: 12.079

7.  Vision-related quality of life in people with central retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire.

Authors:  Vincent A Deramo; Terry A Cox; Arjumand B Syed; Paul P Lee; Sharon Fekrat
Journal:  Arch Ophthalmol       Date:  2003-09

8.  Severity of visual field loss and health-related quality of life.

Authors:  Roberta McKean-Cowdin; Rohit Varma; Joanne Wu; Ron D Hays; Stanley P Azen
Journal:  Am J Ophthalmol       Date:  2007-04-02       Impact factor: 5.258

Review 9.  The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: a systematic review and economic evaluation.

Authors:  J Carlton; J Karnon; C Czoski-Murray; K J Smith; J Marr
Journal:  Health Technol Assess       Date:  2008-06       Impact factor: 4.014

10.  [Measuring patient's quality of life in ophthalmology].

Authors:  C Hirneiss; A S Neubauer; U Welge-Lüssen; K Eibl; A Kampik
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

View more
  13 in total

1.  [Vitreoretinal surgery in Oman].

Authors:  A A Bialasiewicz; R Shenoy; R M Al Saeidi; H M Al-Belushi
Journal:  Ophthalmologe       Date:  2011-02       Impact factor: 1.059

2.  Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial.

Authors:  Kevin D Frick; Lea T Drye; John H Kempen; James P Dunn; Gary N Holland; Paul Latkany; Narsing A Rao; H Nida Sen; Elizabeth A Sugar; Jennifer E Thorne; Robert C Wang; Janet T Holbrook
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-09       Impact factor: 4.799

3.  Vision-Related Functioning in Patients Undergoing Pneumatic Retinopexy vs Vitrectomy for Primary Rhegmatogenous Retinal Detachment: A Post Hoc Exploratory Analysis of the PIVOT Randomized Clinical Trial.

Authors:  Rajeev H Muni; Carolina L M Francisconi; Tina Felfeli; Michael Y K Mak; Alan R Berger; David T Wong; Filiberto Altomare; Louis R Giavedoni; Radha P Kohly; Peter J Kertes; Natalia Figueiredo; Fei Zuo; Kevin E Thorpe; Roxane J Hillier
Journal:  JAMA Ophthalmol       Date:  2020-08-01       Impact factor: 7.389

4.  Development of an Arabic version of the National Eye Institute Visual Function Questionnaire as a tool to study eye diseases patients in Egypt.

Authors:  Nizar Saleh Abdelfattah; Mohamed Amgad; Ahmed A Salama; Marina E Israel; Ghada A Elhawary; Ahmed E Radwan; Mohamed M Elgayar; Tamer M El Nakhal; Islam T Elkhateb; Heba A Hashem; Doha K Embaby; Amira A Elabd; Reem K Elwy; Magdi S Yacoub; Hamdy Salem; Mohamed Abdel-Baqy; Ahmad Kassem
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

5.  [Measurement of glaucoma-specific functionality with the GQL-15 and correlation with parameters of visual function].

Authors:  C Hirneiss; M Vogel; A Kampik; A S Neubauer; M Kernt
Journal:  Ophthalmologe       Date:  2011-10       Impact factor: 1.059

6.  Vision related quality of life in patients with type 2 diabetes in the EUROCONDOR trial.

Authors:  Marina Trento; Olga Durando; Sonia Lavecchia; Lorena Charrier; Franco Cavallo; Miguel Angelo Costa; Cristina Hernández; Rafael Simó; Massimo Porta
Journal:  Endocrine       Date:  2016-09-14       Impact factor: 3.633

7.  Vision-related quality of life in herpetic anterior uveitis patients.

Authors:  Lisette Hoeksema; Leonoor I Los
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

8.  Postoperative vision-related quality of life in macula-off rhegmatogenous retinal detachment patients and its relation to visual function.

Authors:  Mathijs A J van de Put; Lisette Hoeksema; Wouter Wanders; Ilja M Nolte; Johanna M M Hooymans; Leonoor I Los
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

9.  Biometry and visual function of a healthy cohort in Leipzig, Germany.

Authors:  Maria Teresa Zocher; Jos J Rozema; Nicole Oertel; Jens Dawczynski; Peter Wiedemann; Franziska G Rauscher
Journal:  BMC Ophthalmol       Date:  2016-06-07       Impact factor: 2.209

10.  Vision-Related Quality of Life in Patients with Inactive HLA-B27-Associated-Spectrum Anterior Uveitis.

Authors:  Lisette Hoeksema; Leonoor I Los
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.